Wintest
6721
Osaka Yuka Industry
4124
D. Western Therapeutics Institute
4576
Asiro
7378
Hamee
3134
JP Stock MarketDetailed Quotes
5933 Alinco
- 1040
- 00.00%
20min DelayNot Open Dec 16 15:30 JST
21.88BMarket Cap10.29P/E (Static)
1046High1037Low18.60KVolume1041Open1040Pre Close19.36MTurnover117752wk High0.17%Turnover Ratio21.04MShares90252wk Low78.36EPS TTM11.36BFloat Cap1425Historical High10.29P/E (Static)10.92MShs Float206Historical Low101.06EPS LYR0.87%Amplitude42.00Dividend TTM0.66P/B100Lot Size4.04%Div YieldTTM
Alinco Key Stats
Quarterly+Annual
YOY
| (Q2)Sep 20, 2024 | (Q1)Jun 20, 2024 | (FY)Mar 20, 2024 | (Q4)Mar 20, 2024 | (Q3)Dec 20, 2023 | (Q2)Sep 20, 2023 | (Q1)Jun 20, 2023 | (FY)Mar 20, 2023 | (Q4)Mar 20, 2023 | (Q3)Dec 20, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | 8.03%16.29B | 2.69%14.53B | -4.68%57.88B | -6.00%13.18B | -8.18%15.46B | -2.31%15.08B | -1.84%14.15B | 9.88%60.72B | -1.44%14.03B | 17.67%16.84B |
| Cost of revenue | 6.76%12.06B | 3.01%10.47B | -5.19%43.42B | -1.79%10.28B | -8.71%11.68B | -4.30%11.3B | -5.31%10.16B | 9.43%45.8B | -7.58%10.46B | 17.37%12.8B |
| Gross profit | 11.84%4.23B | 1.86%4.06B | -3.10%14.46B | -18.38%2.91B | -6.51%3.78B | 4.14%3.78B | 8.29%3.99B | 11.32%14.92B | 22.45%3.56B | 18.60%4.04B |
| Operating expense | 9.13%3.47B | 8.85%3.51B | 1.41%12.68B | 0.09%3.04B | 2.65%3.23B | 2.28%3.18B | 0.62%3.22B | 1.75%12.5B | -0.61%3.04B | 2.75%3.15B |
| Operating profit | 26.08%762.74M | -27.74%550.78M | -26.40%1.78B | -125.71%-134.51M | -38.67%549.29M | 15.11%604.96M | 59.90%762.19M | 116.34%2.42B | 451.73%523.17M | 159.07%895.57M |
| Net non-operating interest income (expenses) | -34.57%-37.26M | -252.30%-31.15M | -143.60%-75.45M | 15.99%-19.71M | -1,345.24%-19.21M | -102.55%-27.68M | -291.74%-8.84M | -127.33%-30.97M | -105.13%-23.46M | -66.79%1.54M |
| Non-operating interest income | -32.57%4.24M | 133.33%1.69M | -44.82%20.69M | 356.51%11.86M | -87.33%1.82M | 642.79%6.28M | -96.33%723K | 2.41%37.49M | 21.69%2.6M | -21.07%14.37M |
| Non-operating interest expense | 22.15%41.49M | 243.31%32.84M | 40.42%96.14M | 21.15%31.57M | 64.00%21.03M | 134.04%33.97M | -36.51%9.57M | 36.29%68.46M | 92.01%26.06M | -5.41%12.83M |
| Net investment income | -177.08%-140.53M | -47.73%190.96M | -29.56%767.64M | 166.33%109.15M | -46.04%110.85M | -62.92%182.31M | -34.44%365.32M | 126.94%1.09B | -172.76%-164.55M | 19.48%205.41M |
| Gain(Loss) on financial instruments designated as cash flow hedges | ||||||||||
| Gain(Loss) on derecognition of available-for-sale financial assets | 0 | -23.20%64.6M | 360.40%142.53M | 58.42M | 0 | 0 | 84.11M | -54.33%30.96M | 0 | 30.96M |
| Income from associates and other participating interests | 0 | 0 | 80.57%-170.7M | 0 | 97.54%-20.34M | |||||
| Special income (charges) | -100.58%-400K | 127.99%198.94M | 579.68%352.69M | 83.86%148.46M | 120.13%48.04M | 266.49%68.93M | 32.98%87.26M | -114.72%-73.53M | -36.65%80.74M | -194.58%-238.7M |
| Less:Restructuring and mergern&acquisition | ---- | ---- | --0 | --0 | ---- | ---- | ---- | --282.09M | --0 | ---- |
| Less:Other special charges | 100.58%400K | -127.99%-198.94M | -69.11%-352.69M | -83.86%-148.46M | -10.73%-48.04M | -266.49%-68.93M | -32.98%-87.26M | 58.25%-208.56M | 36.65%-80.74M | 82.81%-43.39M |
| Other non-operating income (expenses) | -25.19%35.11M | -0.67%24.09M | 45.99%53.18M | 13.35%-19.13M | -94.02%1.11M | 35.48%46.94M | 365.61%24.25M | -59.04%36.42M | -187.96%-22.07M | 19.13%18.64M |
| Income before tax | -29.22%619.67M | -24.05%998.21M | -8.49%3.02B | -63.77%142.68M | -22.73%690.07M | -11.91%875.46M | 28.57%1.31B | 142.26%3.3B | 124.58%393.83M | 2,523.70%893.09M |
| Income tax | -11.73%256.78M | -24.03%327.43M | -27.32%1.03B | -58.13%71.7M | -46.70%240.86M | -23.22%290.91M | 2.30%431.02M | 53.73%1.42B | 27.15%171.24M | 46.60%451.88M |
| Net income | -37.92%362.9M | -24.06%670.78M | 5.77%1.99B | -68.11%70.98M | 1.82%449.22M | -4.93%584.55M | 47.00%883.27M | 329.62%1.88B | 447.13%222.59M | 227.86%441.21M |
| Net income continuous operations | -37.92%362.9M | -24.06%670.78M | 5.77%1.99B | -68.11%70.98M | 1.82%449.22M | -4.93%584.55M | 47.00%883.27M | 329.61%1.88B | 447.11%222.59M | 227.86%441.21M |
| Noncontrolling interests | 468.93%3.42M | 30.72%583K | -100.17%-566K | 63.12%-652K | -99.83%567K | 61.12%-927K | 110.79%446K | 2,510.93%332.56M | 61.30%-1.77M | 10,893.26%340.85M |
| Net income attributable to the company | -38.60%359.48M | -24.08%670.2M | 28.55%1.99B | -68.07%71.63M | 347.07%448.65M | -5.15%585.48M | 45.92%882.82M | 242.79%1.55B | 395.80%224.35M | 129.35%100.35M |
| Preferred stock dividends | ||||||||||
| Other under preferred stock dividend | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net income attributable to common stockholders | -38.60%359.48M | -24.08%670.2M | 28.55%1.99B | -68.07%71.63M | 347.07%448.65M | -5.15%585.48M | 45.92%882.82M | 242.79%1.55B | 395.80%224.35M | 129.35%100.35M |
| Gross dividend payment | ||||||||||
| Basic earnings per share | -39.06%18.13 | -24.62%33.93 | 27.60%101.06 | -69.00%3.54 | 348.92%22.76 | -5.91%29.75 | 44.77%45.01 | 240.21%79.2 | 394.37%11.42 | 128.66%5.07 |
| Diluted earnings per share | -39.06%18.13 | -24.62%33.93 | 27.60%101.06 | -69.00%3.54 | 348.92%22.76 | -5.91%29.75 | 44.77%45.01 | 240.21%79.2 | 394.37%11.42 | 128.64%5.07 |
| Dividend per share | 5.00%21 | 0 | 2.50%41 | 5.00%21 | 0 | 0.00%20 | 0 | 0.00%40 | 0.00%20 | 0 |
| Currency Unit | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY |
| Accounting Standards | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP |